| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 295 |
| 1 | INFLIXIMAB | 268 |
| 2 | METHOTREXATE SODIUM | 229 |
| 3 | METHOTREXATE | 210 |
| 4 | PREDNISONE | 189 |
| 5 | LENALIDOMIDE | 101 |
| 6 | DEXAMETHASONE | 90 |
| 7 | DEXAMETHASONE 1.5 MG | 90 |
| 8 | PREDNISOLONE | 86 |
| 9 | PREDNISOLONE ORAL | 86 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALEMTUZUMAB | 34 | 0.0018 |
| 1 | RIFAMPICIN | 13 | 0.0013 |
| 2 | ADALIMUMAB-FKJP | 57 | 0.0012 |
| 3 | INFLIXIMAB | 268 | 0.0012 |
| 4 | ADALIMUMAB-AATY | 59 | 0.0012 |
| 5 | ADALIMUMAB-ADAZ | 62 | 0.0011 |
| 6 | MYCOPHENILIC ACID | 21 | 0.0010 |
| 7 | LEVOFLOXACIN | 53 | 0.0009 |
| 8 | PIPERACILLIN AND TAZOBACTAM | 11 | 0.0008 |
| 9 | MYCOPHENOLIC ACID | 27 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 440 |
| 1 | Corticosteroid [EPC] | 404 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 212 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 139 |
| 4 | Thalidomide Analog [EPC] | 120 |
| 5 | Vitamin C [EPC] | 93 |
| 6 | Vitamin B12 [EPC] | 85 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 80 |
| 8 | Vitamin D [EPC] | 80 |
| 9 | Proton Pump Inhibitor [EPC] | 70 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 29 | 0.0050 |
| 1 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 5 | 0.0046 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 34 | 0.0018 |
| 3 | Type I Interferon Receptor Antagonist [EPC] | 3 | 0.0016 |
| 4 | Provitamin D2 Compound [EPC] | 43 | 0.0014 |
| 5 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 21 | 0.0010 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 9 | 0.0007 |
| 8 | Calcitonin [EPC] | 2 | 0.0006 |
| 9 | Asparagine-specific Enzyme [EPC] | 8 | 0.0006 |